Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The study has expanded to include 121 locations, and the website has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.2%
    Check dated 2024-07-23T15:24:13.000Z thumbnail image
  5. Check
    4 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:47:05.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T15:22:55.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T11:11:24.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T09:45:13.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus Genetics related topics: Gastrointestinal stromal tumor Genetic and Rare Diseases Information Center resources: Gastrointestinal Stromal Tumors Drug Information available for: Sunitinib malate Sunitinib Ripretinib FDA Drug and Device Resources'. This change represents an update in the information related to genetics, rare diseases, and drug resources for gastrointestinal stromal tumor treatment in the study.
    Difference
    25%
    Check dated 2024-06-25T08:51:29.000Z thumbnail image

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.